| Fund ID | 805-6092160414 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 22% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Great Point Partners IV, L.P. | Private Equity | $547.9M |
| Great Point Partners III, LP | Private Equity | $271M |
| Biomedical Offshore Value Fund, Ltd. | Hedge | $130.1M |
Biomedical Value Fund, L.P. reports $243.6 million in gross assets, among the top 27% of private funds by size.
The stated minimum investment is $1 million.
Biomedical Value Fund, L.P. is managed by Great Point Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.